Brief: Sarepta Therapeutics Announces Submission Of Clinical Trial Application For Srp-1005
07/01/2026 14:27
Jan 7 (Reuters) - Sarepta Therapeutics Inc SRPT.O: SAREPTA THERAPEUTICS ANNOUNCES SUBMISSION OF CLINICAL TRIAL APPLICATION FOR SRP-1005, ITS INVESTIGATIONAL TREATMENT FOR HUNTINGTON’S DISEASE SAREPTA THERAPEUTICS INC - EXPECTS TO INITIATE SRP-1005 TRIAL IN Q2 2026 Source text: ID:nBw3kSW8Ka Further company coverage: SRPT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sarepta Therapeutics
See all newsUS RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB
U.S. STOCKS ON THE MOVE-Best Buy, Peloton, Apple
Dyne, Sarepta shares tumble as Novartis setback weighs on muscle disease drug developers
U.S. STOCKS ON THE MOVE-Qualcomm, Eaton, Howmet Aerospace
Sarepta, Dyne fall after Novartis muscle disorder trial failure